NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: GPTHEALTH · data 2026-10-31
GPT Healthcare Limited
In plain words
Price: 24.2% below its 52-week high of ₹175.
Delivery: 56.3% of traded shares were kept for delivery over the last 10 sessions, against 56.1% over the last 60.
Latest results: a net profit of ₹9 cr for the quarter ended Dec 2025.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹492 cr |
| Net profit (last 12 months) | ₹47 cr |
| Sales growth, 3 years (yearly) | 25.0% |
| Profit growth, 3 years (yearly) | 26.0% |
At a glance
Promoters 65.6%, pledged 0.0%, institutions 9.7%.
P/E 23.0, dividend yield 1.9%. Price relative to earnings and book value (low is cheaper, not better).
ROE 16.3%, ROCE 16.2%, operating margin 12.9%: how much profit it earns on the money it uses.
Debt/equity 0.34, Profit growth 26.0% and sales growth 25.0% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 26.0% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q3 FY26)
GPTHEALTH Q3 FY26 results (standalone figures, as filed on NSE).
Revenue was ₹120.16 crore.
Net profit was ₹9.37 crore.
Operating margin was 17.2%.
EPS was ₹1.14.
GPTHEALTH के Q3 FY26 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।
राजस्व: ₹120.16 करोड़।
शुद्ध मुनाफ़ा: ₹9.37 करोड़।
ऑपरेटिंग मार्जिन: 17.2%।
EPS: ₹1.14।
GPTHEALTHના Q3 FY26 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹120.16 કરોડ.
ચોખ્ખો નફો: ₹9.37 કરોડ.
ઓપરેટિંગ માર્જિન: 17.2%.
EPS: ₹1.14.
Written from the filed numbers. Not a recommendation.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 56.3% over the last 20 sessions vs 54.8% in the 40 before (1.03x); shares delivered per day 0.65x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Results
- 30 Jul 26Dividend Dividend ₹1.5 (ex-date) +2.0% next session
- 2 Feb 26Results Q3 FY26 results: net profit ₹9.4 cr +0.3% next session
- 14 Nov 25Dividend Dividend ₹1 (ex-date) +2.8% next session
- 29 Jul 25Dividend Dividend ₹1.5 (ex-date) +8.2% next session
- 28 Nov 24Dividend Dividend ₹1 (ex-date) +2.8% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (standalone)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Dec 2025 | ₹120 cr | ₹9 cr | — | 17.2% | 1.14 |
Shareholding trend
| Holder | Sept 2025 | Jun 2025 |
|---|---|---|
| Promoters | 65.57% | 65.57% |
| Foreign institutions (FII) | 3.20% | 4.96% |
| Domestic institutions (DII) | 6.46% | 9.32% |
| Mutual funds | 4.64% | 4.31% |
| Retail investors | 15.68% | 14.13% |
| Number of shareholders | 67,617 | 67,060 |
Common questions
What was GPT Healthcare Limited's latest quarterly profit?
GPT Healthcare Limited reported a net profit of ₹9 cr for the quarter ended Dec 2025, on revenue of ₹120 cr.
How much do promoters hold in GPT Healthcare Limited?
Promoters held 65.57% of GPT Healthcare Limited at the end of Sept 2025, with 0.00% of promoter shares pledged.
Is GPT Healthcare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.34.
What is GPT Healthcare Limited's P/E ratio?
About 23, based on the last 12 months' earnings and a price of ₹132.68 (data 2026-10-31).
What is the 52-week high and low of GPT Healthcare Limited?
The 52-week high is ₹175 and the 52-week low is ₹115.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| GPT Healthcare Limited | ₹132.68 | ₹1,089 cr | 23 | — | 16.3% | 16.2% | 0.34 | -11.6% |
| Indraprastha Medical Corporation Limited | ₹305.65 | ₹2,797 cr | 14.9 | — | 27.5% | 30% | 0.05 | -46.9% |
| KMC Speciality Hospitals (India) Limited | ₹148.39 | ₹2,422 cr | 43.4 | — | 24.9% | 25.1% | 0.4 | +7.8% |
| Shalby Ltd. | ₹120.64 | ₹1,306 cr | 32.8 | — | 3.7% | 6% | 0.59 | -51.3% |
| Gujarat Kidney & Super Speciality Ltd. | ₹163.31 | ₹1,289 cr | 81.3 | — | 11.1% | 14.7% | 0.12 | +36.1% |
| KRM Ayurveda Ltd. | ₹225.45 | ₹479 cr | — | — | — | — | — | +31.0% |
Compare GPTHEALTH with INDRAMEDCO in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open GPTHEALTH in NSE Scanner →